- Home
- ARDX vs AMLX Comparison
ARDX vs AMLX Comparison
Compare ARDX & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- AMLX
- Stock Information
- Founded
- ARDX 2007
- AMLX 2014
- Country
- ARDX United States
- AMLX United States
- Employees
- ARDX N/A
- AMLX N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- ARDX Health Care
- AMLX Health Care
- Exchange
- ARDX Nasdaq
- AMLX Nasdaq
- Market Cap
- ARDX 882.9M
- AMLX 749.9M
- IPO Year
- ARDX 2014
- AMLX 2022
- Fundamental
- Price
- ARDX $5.04
- AMLX $14.90
- Analyst Decision
- ARDX Strong Buy
- AMLX Strong Buy
- Analyst Count
- ARDX 9
- AMLX 7
- Target Price
- ARDX $10.50
- AMLX $16.86
- AVG Volume (30 Days)
- ARDX 3.2M
- AMLX 1.9M
- Earning Date
- ARDX 10-30-2025
- AMLX 11-06-2025
- Dividend Yield
- ARDX N/A
- AMLX N/A
- EPS Growth
- ARDX N/A
- AMLX N/A
- EPS
- ARDX N/A
- AMLX N/A
- Revenue
- ARDX $386,146,000.00
- AMLX N/A
- Revenue This Year
- ARDX $17.34
- AMLX N/A
- Revenue Next Year
- ARDX $27.08
- AMLX N/A
- P/E Ratio
- ARDX N/A
- AMLX N/A
- Revenue Growth
- ARDX 83.88
- AMLX N/A
- 52 Week Low
- ARDX $3.21
- AMLX $2.60
- 52 Week High
- ARDX $6.78
- AMLX $15.94
- Technical
- Relative Strength Index (RSI)
- ARDX 33.54
- AMLX 62.33
- Support Level
- ARDX $4.71
- AMLX $13.60
- Resistance Level
- ARDX $5.27
- AMLX $15.15
- Average True Range (ATR)
- ARDX 0.19
- AMLX 1.05
- MACD
- ARDX -0.04
- AMLX -0.03
- Stochastic Oscillator
- ARDX 30.80
- AMLX 71.09
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.